Brazilian healthtech ISA Saúde raised a $30M Series B round led by the International Finance Corporation (IFC), with participation from IDB Lab, Dalus Capital, and Endeavor Catalyst.
ISA Saúde provides hospital-level medical care at home, from routine services such as blood testing to complex treatments like rehabilitation and palliative care.
ISA Saúde will use the funds to expand into more cities, strengthen B2B partnerships with Brazil’s leading health insurers, expand its service portfolio, enhance patient experience through AI, and make strategic acquisitions.
“With this new investment, we’ll scale our operation and accelerate access to technologies that benefit patients, families, and healthcare professionals alike,” said ISA Saúde’s co-founder and CEO Fernando Parés.
Founded in 2019, ISA Saúde currently serves over 1.5K patients daily across 60 cities in Brazil.
